<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
  <channel>
    <title>Rosenson, Robert (19..-....)</title>
    <description><![CDATA[ Professeur de médecine à la Mount Sinai school of médicine (New-York) et Directeur du Cardiometabolic disorders Mount Sinai Heart (2012)

 ]]></description>
    <link>https://www.canal-u.tv/intervenants/rosenson-robert-254010636</link>
    <lastBuildDate>Wed, 08 Jun 2022 17:08:39 +0100</lastBuildDate>
    <generator>Canal-U</generator>
    <language>fr</language>
        <itunes:category text="Education"></itunes:category>
    <itunes:author >Canal-U</itunes:author>
    <itunes:explicit >No</itunes:explicit>
    <itunes:owner >
      <itunes:name>Rosenson, Robert (19..-....)</itunes:name>
      <itunes:email>contact@canal-u.tv</itunes:email>
    </itunes:owner>
          <item>
        <title>Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 5 : Will we be able to answer the question of HDL as a therapeutic target after the CETP inhibitor trials? (Robert ROSENSON)</title>
        <link>https://www.canal-u.tv/62211</link>
                  <description><![CDATA[ Will new compounds be able to reduce the residual risk in high risk patients when treatment targets based on new ESC guidelines have been achieved (e.g. LDL-C lesser than 70mg/dl)? ]]></description>
                          <pubDate>Fri, 22 Feb 2013 12:00:00 +0100</pubDate>
                <guid isPermaLink="false">https://www.canal-u.tv/62211</guid>
                  <enclosure url="https://vod.canal-u.tv/hls/cutms/,cardiovascular.clinical.trialists.cvct.forum.a.paris.2012.workshop.5.identifying.new.targets.monoclonal.antibody.inhibitor.of.pcsk9.wolfgang.koenig.copie._11422/modigliani_workshop5_robertrosenson_hd.mp4,cardiovascular.clinical.trialists.cvct.forum.a.paris.2012.workshop.5.identifying.new.targets.monoclonal.antibody.inhibitor.of.pcsk9.wolfgang.koenig.copie._11422/modigliani_workshop5_robertrosenson_std.mp4,cardiovascular.clinical.trialists.cvct.forum.a.paris.2012.workshop.5.identifying.new.targets.monoclonal.antibody.inhibitor.of.pcsk9.wolfgang.koenig.copie._11422/modigliani_workshop5_robertrosenson_bd.mp4,.urlset/master.m3u8" length="3497" type="application/x-mpegurl" />
                      </item>
      </channel>
</rss>
